Stately Bio develops cell therapies using a machine learning-powered live-cell imaging platform to enhance process development and quality control for biopharma companies.

Aperiam Bio is a protein engineering firm that improves protein stability and function through a unique 3D computer vision algorithm, targeting applications in consumer products and pulmonary therapeutics.